MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$2.67 USD
+0.17 (6.80%)
Updated May 1, 2024 04:00 PM ET
After-Market: $2.69 +0.02 (0.75%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for MDxHealth SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -37.90 | -26.84 | -27.12 | -43.17 |
Depreciation/Amortization & Depletion | NA | 4.91 | 3.04 | 3.33 | 3.42 |
Net Change from Assets/Liabilities | NA | -1.57 | 0.36 | 1.98 | 10.30 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.44 | 0.90 | 1.57 | 7.16 |
Net Cash From Operating Activities | NA | -34.12 | -22.55 | -20.24 | -22.29 |
Property & Equipment | NA | -2.79 | -0.90 | -0.54 | -0.07 |
Acquisition/ Disposition of Subsidiaries | NA | -25.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -1.37 | 0.01 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -29.16 | -0.89 | -0.54 | -0.07 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 68.57 | 13.88 | 9.58 |
Issuance (Repayment) of Debt | NA | 23.49 | 0.00 | 2.32 | 9.52 |
Increase (Decrease) Short-Term Debt | NA | -1.36 | -1.06 | -0.83 | -0.82 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -1.29 | -1.01 | -1.07 | -0.32 |
Net Cash from Financing Activities | NA | 20.84 | 66.50 | 14.29 | 17.97 |
Effect of Exchange Rate Changes | NA | -0.56 | -0.52 | 0.39 | 0.24 |
Net Change In Cash & Equivalents | NA | -43.00 | 42.55 | -6.10 | -4.15 |
Cash at Beginning of Period | NA | 58.50 | 15.95 | 22.05 | 26.20 |
Cash at End of Period | NA | 15.50 | 58.50 | 15.95 | 22.05 |
Diluted Net EPS | -1.66 | -2.80 | -2.40 | -3.40 | -6.90 |
Fiscal Year End for MDxHealth SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | NA | -16.46 | -8.72 |
Depreciation/Amortization & Depletion | NA | NA | NA | 3.41 | 1.64 |
Net Change from Assets/Liabilities | NA | NA | NA | 2.91 | 1.84 |
Net Cash from Discontinued Operations | NA | NA | NA | NA | 0.00 |
Other Operating Activities | NA | NA | NA | 0.28 | 0.97 |
Net Cash From Operating Activities | NA | NA | NA | -9.86 | -4.27 |
Property & Equipment | NA | NA | NA | -2.15 | -0.79 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | NA | 0.00 |
Investments | NA | NA | NA | NA | 0.00 |
Other Investing Activities | NA | NA | NA | -0.66 | -0.46 |
Net Cash from Investing Activities | NA | NA | NA | -2.82 | -1.24 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | NA | 39.60 | 39.60 |
Issuance (Repayment) of Debt | NA | NA | NA | -0.32 | -0.16 |
Increase (Decrease) Short-Term Debt | NA | NA | NA | -0.71 | -0.35 |
Payment of Dividends & Other Distributions | NA | NA | NA | NA | 0.00 |
Other Financing Activities | NA | NA | NA | -1.73 | -0.83 |
Net Cash from Financing Activities | NA | NA | NA | 36.84 | 38.27 |
Effect of Exchange Rate Changes | NA | NA | NA | -0.19 | -0.01 |
Net Change In Cash & Equivalents | NA | NA | NA | 23.97 | 32.75 |
Cash at Beginning of Period | NA | NA | NA | 15.50 | 15.50 |
Cash at End of Period | NA | NA | NA | 39.47 | 48.25 |
Diluted Net EPS | NA | -0.39 | NA | NA | -0.50 |